Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/10/1998 | EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
06/10/1998 | EP0845994A1 Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
06/10/1998 | EP0845992A1 Method of promoting angiogenesis |
06/10/1998 | EP0845991A2 Use of phenol substituted diphosphonates as antineoplastic agents |
06/10/1998 | EP0845990A1 New use of pregnane-diones as analgesic agents |
06/10/1998 | EP0845989A2 Pain-alleviating drug composition and method for alleviating pain |
06/10/1998 | EP0845988A1 Novel fused isoquinolines as dopamine receptor ligands |
06/10/1998 | EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
06/10/1998 | EP0845986A1 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine |
06/10/1998 | EP0845985A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
06/10/1998 | EP0845984A1 Use of aminoadamantane compounds as immunoregulators |
06/10/1998 | EP0845983A2 Pharmaceutical composition with trypanocidal properties |
06/10/1998 | EP0845981A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
06/10/1998 | EP0845974A1 Compositions containing a peptide cell growth promoter |
06/10/1998 | EP0845939A2 Lysosomal proteins produced in the milk of transgenic animals |
06/10/1998 | EP0831817A4 Antigen-processing cell-targeted conjugates |
06/10/1998 | EP0746317B1 Sublingual or buccal pharmaceutical composition |
06/10/1998 | EP0721346B1 Methods for inducing antigen-specific t cell tolerance |
06/10/1998 | EP0710113B1 Preparation for improving the blood supply containing hard magnetic particles |
06/10/1998 | EP0710105A4 Synergistic anthelmintic compositions |
06/10/1998 | EP0703725A4 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes |
06/10/1998 | EP0696196A4 Use of oral diazoxide for the treatment of disorders in glucose metabolism |
06/10/1998 | EP0693054B1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors |
06/10/1998 | EP0684958B1 Polymers containing guanidino groups for use in therapy |
06/10/1998 | EP0684942B1 Method for preparing quinoline carboxylic acids and derivatives thereof |
06/10/1998 | EP0675719B1 Novel combination of benzoquinazoline antifolates and protecting agents |
06/10/1998 | EP0674508B1 4-guanidinobutyramide for improving blood circulation |
06/10/1998 | EP0673239B1 Aqueous antibiotic composition for veterinary use |
06/10/1998 | EP0629210B1 Peptide linkage unit comprising methylene phosphinic acid |
06/10/1998 | EP0603229B1 Quinuclidine esters process and intermediates for their preparation and pharmaceutical compositions containing them |
06/10/1998 | DE19652418A1 Verwendung von Nucleosiden, Nucleobasen und deren Derivaten zum Herabsetzen toxischer Nebenwirkungen von Cytostatika Use of nucleosides, nucleobases and their derivatives for reducing toxic side effects of cytostatics |
06/10/1998 | DE19652408A1 Steroidester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung Steroid esters, to processes for their preparation and their pharmaceutical use |
06/10/1998 | DE19650975A1 Neue heterocyclisch substituierte Benzamide und deren Anwendung New heterocyclic-substituted benzamides and their application |
06/10/1998 | DE19650778A1 Dopamine receptor antagonists |
06/10/1998 | DE19650755A1 Use of ribose to increase physical performance of living organisms, |
06/10/1998 | DE19650754A1 Use of ribose to treat and/or prevent stroke |
06/10/1998 | DE19644998C1 Verwendung von Adamantanaminen oder strukturanaloger Verbindungen zur Bekämpfung von Borna Disease Virus und zur Prophylaxe und Behandlung von Affekterkrankungen und anderen mit BDV-Infektionen verbundenen Störungen bei Mensch und Tier Use of adamantane structure or analogous compounds to combat Borna disease virus and for the prophylaxis and treatment of affective disorders and other disorders associated with BDV infections in humans and animals |
06/10/1998 | CN1184531A Method for diagnosing a patient for chlamydia |
06/10/1998 | CN1184483A Fucopeptides |
06/10/1998 | CN1184481A Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones |
06/10/1998 | CN1184480A Esters of carbapenems |
06/10/1998 | CN1184475A Tetralin compounds with MDR activity |
06/10/1998 | CN1184474A Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
06/10/1998 | CN1184473A 6- carboxamido dihydropyran derivatives |
06/10/1998 | CN1184472A Reversible protease inhibitors |
06/10/1998 | CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
06/10/1998 | CN1184469A 1 -phenylpyrazole-3 -carboxamides acting on neurotensin receptors |
06/10/1998 | CN1184461A Novel ether compound and process for producing the same |
06/10/1998 | CN1184430A Compositions of interleukin and pyrimidine nucleosides |
06/10/1998 | CN1184429A Pharmaceutical compositions for the treatment of alcohol addiction |
06/10/1998 | CN1184427A 抗真菌组合物 Antifungal compositions |
06/10/1998 | CN1184426A Levobupivacaine and its use as an anaesthetic in pregnant women |
06/10/1998 | CN1184425A 5 -substituted -3 -(1, 2, 3, 6 -tetrahydro -pyridin -4 -yl) - and 3 -(piperidin -4 -yl) -1h -indoles: new 5 -HT1f agonists |
06/10/1998 | CN1184424A New pharmacological use of all-receptor antagonists |
06/10/1998 | CN1184423A Nodulisporic acid derivatives |
06/10/1998 | CN1184422A Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction |
06/10/1998 | CN1184421A Treatment of inflammatory bowel disease using oral dosage forms of omega -3 polyunsaturated acids |
06/10/1998 | CN1184420A Production scale method of forming microparticles |
06/10/1998 | CN1184407A Stress regulator for animals |
06/10/1998 | CN1184404A Improved method for controlling ectoparasites |
06/10/1998 | CN1184112A Inositolglycans having insulin-like action |
06/10/1998 | CN1184110A 1 -carba -(dethia) -cephalosporin derivatives |
06/10/1998 | CN1184108A Anti-viral compounds |
06/10/1998 | CN1184106A Benzothiazole quinone and its preparation and use |
06/10/1998 | CN1184105A Substituted thiazolidine derivatives and pharmaceutical compositions containing them and use thereof |
06/10/1998 | CN1184104A 3 -hydroxy -pyridine -2 -carboxylic amide ester, and its preparation and its application as medicine |
06/10/1998 | CN1183961A Liniment film for onychomycosis and its preparation technology |
06/10/1998 | CN1183960A Controlled release pharmaceutical compositions for oral administration containing nifedipine as active substance |
06/10/1998 | CN1183959A Antibiotic composite for restraining beta-lactamase |
06/10/1998 | CN1183911A 口香糖 Chewing gum |
06/10/1998 | CN1038681C Producing process for triazole derivative |
06/10/1998 | CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use |
06/10/1998 | CN1038643C Preparation method of injection for treating hircus |
06/10/1998 | CA2224351A1 Novel organotin compounds and compositions containing these compounds |
06/09/1998 | US5763673 Diarylheptanoide derivative and pharmaceutical composition comprising the same |
06/09/1998 | US5763638 Preparation of aromatic nitriles |
06/09/1998 | US5763631 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof |
06/09/1998 | US5763621 Reaction of acid compound with hydroxylamine compound or amidation of acid |
06/09/1998 | US5763614 1,4-dihydropyridine derivatives and methods of producing the same |
06/09/1998 | US5763611 Treating osteoporosis, rheumatoid arthritis |
06/09/1998 | US5763606 Coupling a silylated compound with a purine or pyrimidine base with a bicyclic intermediate and coupling with a lewis acid in solvent, reaction with reducing agent |
06/09/1998 | US5763604 Anticoagulants |
06/09/1998 | US5763603 Crystalline tazobactam, and its production and use |
06/09/1998 | US5763588 Pyrimidine derivatives for labeled binding partners |
06/09/1998 | US5763582 Derivatives of triterpenoid acids and uses thereof |
06/09/1998 | US5763569 Polypeptides as calcium receptors to generate antibodies |
06/09/1998 | US5763504 Photcurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
06/09/1998 | US5763496 Selected from catechols and ortho-methoxyphenols |
06/09/1998 | US5763494 Pharmaceutical compositions comprising isovaleramide |
06/09/1998 | US5763493 Stabilized pharmaceutical |
06/09/1998 | US5763492 Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors |
06/09/1998 | US5763491 Method for enhancing outflow of aqueous humor in treatment of glaucoma |
06/09/1998 | US5763490 Treating prostate cancer with tartrate ions |
06/09/1998 | US5763489 Naphthalene derivatives as prostaglandin I2 agonsists |
06/09/1998 | US5763488 Methods and compositions using butyrate esters of threitol |
06/09/1998 | US5763487 Skin disorders, cardiovascular disorders and cosmetics |
06/09/1998 | US5763486 Process for preparing a composition for the treatment of thermal or chemical burns |
06/09/1998 | US5763485 Method of treating catabolic, gut-associated pathological processes and impaired host defenses |
06/09/1998 | US5763484 Metabolites of linoleic acid and a-linolenic acid |
06/09/1998 | US5763480 Inhibitors of cell-medicated disorders |